Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study

CONTEXT: Observational studies of insulin degludec (degludec) with hypoglycemia events prospectively recorded are lacking. OBJECTIVE: To evaluate the safety and effectiveness of degludec in patients with type 1 diabetes (T1D) or type 2 diabetes (T2D) switching from other basal insulins in routine ca...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Endocrinol Metab
Auteurs principaux: Fadini, Gian Paolo, Feher, Michael, Hansen, Troels Krarup, de Valk, Harold W, Koefoed, Mette Marie, Wolden, Michael, Zimmermann, Esther, Jendle, Johan
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2019
Sujets:
Clinical Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6812737/
https://ncbi.nlm.nih.gov/pubmed/31397845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2019-01021
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires